Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
04/2004
04/14/2004EP1406615A1 Kinase inhibitors and the use thereof
04/14/2004EP1406614A2 Carvedilol polymorph
04/14/2004EP1406605A1 Carbamates of 2-heterocyclic-1,2-ethanediols
04/14/2004EP1189583A4 Indole derivatives
04/14/2004EP0839041B1 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts
04/14/2004EP0724561B1 Calcium receptor-active arylalkyl amines
04/14/2004EP0706515B1 Intercalators having affinity for dna and methods of use
04/14/2004CN1489458A Inhibitors against the production and releaseof inflammator cytokines
04/14/2004CN1488620A 2-phenyl-camphol propionate derivativ and synthesizing method thereof
04/14/2004CN1145608C Quanternary ammonium compounds as anti-tussive agents
04/13/2004US6720429 For acrylic polymers with controlled molecular weight and narrow polydispersity
04/13/2004US6720351 1h-indole-2-carboxylic acid (2-(benzyl(methyl)amino) -2-oxo-1-phenylethyl)amides; triamide microsomal triglyceride transfer protein (mtp) and apolipoprotein b (apo b) inhibitors; obesity; antilipemic agents
04/13/2004US6720339 Such as n-phenyl-4-oxo-6,6-dimethyl-4,5,6,7-tetrahydro-1h-indole-3-carboxamide; for diagnosis and treatment of anxiety, sleep and seizure disorders, overdose with benzodiazepine drugs, and for memory enhancement
04/13/2004US6720338 Bcl-x1 inhibiting compositions and methods of promoting apoptosis in a mammal
04/13/2004US6720335 Sulfonamide inhibitors of aspartyl protease
04/13/2004US6720320 Phenoxypropylamine compounds
04/13/2004US6719811 5,6-dihydroxyindolines, as an oxidation dye precursor for the production of oxidative dyeing compositions
04/08/2004WO2004012722A3 Bicifadine formulation
04/08/2004WO2004010761A3 Pesticidal cyanine dye derivatives
04/08/2004WO2004000205A3 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
04/08/2004WO2003068732A3 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds
04/08/2004WO2003027068A3 Substituted amines for the treatment of neurological disorders
04/08/2004WO2003018553A8 Oral antidiabetic agents
04/08/2004US20040068155 Obtaining anthracene and carbazole by melt-crystallization
04/08/2004US20040068115 Charge transport compositions and electronic devices made with such compositions
04/08/2004US20040068012 Anticancer agents; protease enzyme inhibitor
04/08/2004US20040068001 Using hydroxy-3-methylglutaryl/3-/ coenzyme inhibitor
04/08/2004US20040067999 Carbazole derivatives and their use as neuropeptide y5 receptor ligands
04/08/2004US20040067997 Respiratory syncytial virus
04/08/2004US20040067988 Anticoagulants
04/08/2004US20040067949 Substituted indoles which are parp inhibitors
04/08/2004US20040067931 Benzimidazolidinone derivatives as muscarinic agents
04/08/2004US20040067531 Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
04/08/2004US20040066135 Electronic devices made with electron transport and/or anti-quenching layers
04/07/2004EP1406127A2 Organophotoreceptor with a compound having a toluidine group
04/07/2004EP1405852A1 Diamine derivatives
04/07/2004EP1404659A1 4-aryl quinols and analogs thereof as therapeutic agents
04/07/2004EP1404653A1 Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion
04/07/2004EP1404650A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
04/07/2004EP1404369A1 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases
04/07/2004EP1404317A1 5-halo-tryptamine derivatives used as ligands of the 5-ht 6? and/or 5-ht 7? serotonin receptors
04/07/2004EP1404316A1 Cycloalkylpyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives as gaba-a receptor ligands
04/07/2004EP0973512B1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
04/07/2004CN1487925A Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors
04/07/2004CN1487923A Process for the preparation of (3-cyano-1H-indol-7-yl) (4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof
04/07/2004CN1487922A Process for the preparation of heterocgclic indene analogs
04/07/2004CN1487910A Obtaining anthracene and carbazole by melt-crystallization
04/07/2004CN1144820C Process for preparing condensation compound
04/07/2004CN1144800C Indolyl derivatives as 5-hydroxytryptamine medicine
04/07/2004CN1144793C Polar-substituted hydrocarbons
04/06/2004US6717013 Easily attained with high positional selectivity and yield; intermediates and raw materials
04/06/2004US6716983 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
04/06/2004US6716980 Cyclization and acylation of carbamate
04/06/2004US6716868 (-)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
04/06/2004US6716852 Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors
04/06/2004US6716840 Agonists of the melanocortin-4 receptor (?mc-4r?); useful treating obesity and type 2 diabetes
04/06/2004US6716837 Heterocyclic compounds for the treatment of migraine
04/06/2004US6716832 Arylphenyl-substituted cyclic ketoenols
04/06/2004US6716628 Chondrogenesis promoters and indolin-2-one derivatives
04/06/2004US6716605 Indole derivatives having an antiviral activity
04/06/2004US6716413 Indole compounds as tissue-specific exogenous optical agents
04/06/2004CA2223927C Detection of transmembrane potentials by optical methods
04/06/2004CA2075926C Hydroquinone amino-acid esters, method of preparation, and pharmaceutical or cosmetic compositions containing them
04/06/2004CA2067381C Treatment of hiv infections and compounds useful therein
04/01/2004WO2004027078A2 Fluorinated dendrons and self-organizing ultrahigh density nanocylinder compositions
04/01/2004WO2004026837A2 Histamine h3 receptor antagonists, preparaton and therapeutic uses
04/01/2004WO2004026831A1 2,4-substituted indoles and their use as 5-ht6 modulators
04/01/2004WO2004026830A1 2,7-substituted indoles and their use as 5-ht6 modulators
04/01/2004WO2004026829A2 Heterocyclically substituted indolinones and their use as receptor tyrosine kinase inhibitors
04/01/2004WO2004026292A1 Antitussives
04/01/2004WO2004026264A2 Novel aromatic compounds possessing antifungal or antibacterial activity
04/01/2004WO2004026237A2 Compounds for the treatment of premature ejaculation
04/01/2004WO2004026236A2 Cyclopentyl indole derivatives
04/01/2004WO2004018475A3 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
04/01/2004WO2004006352A3 Electronic devices made with electron transport and/or anti-quenching layers
04/01/2004WO2003099819A3 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
04/01/2004WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
04/01/2004WO2003097597A3 Indole derivatives and the use thereof as cb2 receptor ligands
04/01/2004WO2003084943A3 Terphenyl derivatives, preparation thereof, compositions containing same
04/01/2004WO2003082874A3 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments
04/01/2004WO2003066597A3 Guanidino compounds
04/01/2004WO2002076402A3 Fatty amine drug conjugates
04/01/2004US20040063967 Antiinflammatory agents; sepsis shock; phospholipase inhibitors
04/01/2004US20040063959 Esters and amides as PLA2 inhibitors
04/01/2004US20040063942 Spiro-indolines as Y5 receptor antagonists
04/01/2004US20040063941 Novel spla2 inhibitors
04/01/2004US20040063939 Phosphodiesterase inhibitor
04/01/2004US20040063897 Method for the preparation poly(etherimide)s
04/01/2004US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes
04/01/2004US20040063774 Heterocyclic quinones as pharmaceutical agents
04/01/2004US20040063773 Adminstering a pyrrole substituted 2-indolinone compound to a human for the treatment of protein kinase related cellular disorders such as cancer, autoimmune disorders, diabetes, rheumatoid arthritis, angiogenesis and osteoarthritis
04/01/2004US20040063768 Cyclopentylindole derivatives are useful for the treatment of depression, attention deficit hyperactivity disorder, obsessive-compulsive disorder, post-trauma stress, substance abuse and sexual disorders
04/01/2004US20040063758 Alkylating 5-nitroindole with 6-bromohexyl acetate to form a 6-(N-(5-nitroindolyl)) hexyl acetate, hydrolyzing to form alcohol of above ester, estrifying with nicotinic acid, and methylating the intermediate
04/01/2004US20040063746 For treatment of HIV
04/01/2004US20040063724 Neurotransmitter 5-hydroxytryptamine-6 (5-HT6) antagonists
04/01/2004US20040063723 One pot synthesis; formylation, oximination, cyanation, saponification and amidation of indole ester
04/01/2004US20040063692 Bazedoxifene treatment regimens
04/01/2004US20040063645 Such as ((2-(3-guanidino-2-hydroxy-propylcarbamoyl)-1H-indol-5-yl)-amide)
04/01/2004US20040063175 Transgenic cell for preparation of monatin; food and beverage sweetening
04/01/2004US20040063012 For use in electrophotography